RPS13 Antibody

How do I select RPS13 antibodies with optimal cross-reactivity for multi-species studies?

Methodological Guidance:

• Species Reactivity Comparison:

  Antibody Catalog	Reactivity	Applications	Immunogen Type
  16680-1-AP	Human, Mouse, Rat	WB, IHC, IF/ICC	RPS13 fusion protein
  ABIN2786561	Human, Mouse, Rat, Zebrafish, Yeast	WB	Synthetic peptide (middle region)
  PA5-52235	Human, Mouse, Rat	WB	Full-length protein sequence

  • Selection Criteria: Prioritize antibodies validated for your target species. For yeast (86% homology) or zebrafish (100%), ABIN2786561 shows broader predicted reactivity .

• Epitope Considerations:

  • Full-Length vs. Peptide Epitopes: PA5-52235 targets the full protein sequence, potentially capturing conformational epitopes, while 16680-1-AP and ABIN2786561 use linear epitopes (fusion protein and middle region, respectively) .

What dilutions should I use for Western Blotting (WB), Immunohistochemistry (IHC), and Immunofluorescence (IF)?

Standardized Protocols:

• Note: Titrate antibodies in-house to optimize signal-to-noise ratios. For IHC, citrate buffer (pH 6.0) may substitute TE buffer if antigen retrieval efficacy varies .

How do I validate RPS13 antibody specificity in WB experiments?

Validation Workflow:

• Positive Controls: Use lysates from MCF-7 cells or mouse/rat uterus tissue, where RPS13 is known to be expressed .

• Negative Controls: Include lysates from RPS13-deficient cell lines or species with low homology (e.g., yeast, where ABIN2786561 has 86% predicted reactivity) .

• SDS-PAGE Confirmation: Compare observed bands to calculated MW (17 kDa) and reported sizes (14–17 kDa) . Discrepancies may indicate post-translational modifications or alternative splicing .

What antigen retrieval methods are most effective for RPS13 IHC?

Optimized Protocols:

• Critical Notes:

  • Use proteinase K treatment cautiously, as RPS13 is cytoplasmic and may degrade .

  • Combine with blocking agents (e.g., BSA) to reduce non-specific binding in paraffin-embedded tissues .

How do I interpret unexpected protein bands in RPS13 WB?

Troubleshooting Table:

What strategies can address weak or absent signals in RPS13 IHC?

Advanced Optimization:

• Antigen Retrieval: Compare TE buffer (pH 9.0) and citrate buffer (pH 6.0) efficacy. Time and temperature optimization may enhance epitope accessibility .

• Primary Antibody Dilution: Test beyond the recommended 1:50–1:500 range (e.g., 1:25 or 1:1,000) with signal amplification systems (e.g., TSA kits).

• Fixation Methods:

  • Paraffin-Embedded Tissues: Optimize fixation time (10–24 hours in 4% PFA) and dehydration protocols .

  • Frozen Sections: Use ice-cold methanol/acetone fixation to preserve epitopes for IF/ICC .

Why does the observed molecular weight of RPS13 differ from its calculated value?

Mechanistic Insights:

• Key Takeaway: RPS13’s role in ribosome assembly may involve dynamic modifications. Validate with mass spectrometry or functional assays (e.g., ribosome binding assays) .

How can I design experiments to study RPS13’s role in ribosome assembly?

Experimental Framework:

• Knockout Models: Use CRISPR-edited RPS13-deficient cells to assess ribosomal subunit (40S) stability. Monitor 18S rRNA processing and ribosome profiling data .

• Co-Localization Studies: Perform IF/ICC with antibodies against ribosomal markers (e.g., RPS6, RPL11) to map RPS13’s subcellular distribution during translation .

• RNAi Knockdown: Transfect siRNAs targeting RPS13 and quantify ribosome biogenesis defects via sucrose gradient ultracentrifugation .

What IF/ICC protocols maximize RPS13 signal specificity?

Optimized IF/ICC Workflow:

How do I address antibody cross-reactivity in evolutionary conserved proteins like RPS13?

Mitigation Strategies:

• Pre-Absorption: Incubate antibodies with lysates from non-target species (e.g., yeast) to remove cross-reactive IgG .

• Epitope Masking: Use peptide competition assays. For ABIN2786561 (middle region), add excess synthetic peptide (ILRILKSKGL APDLPEDLYH LIKKAVAVRK) .

• Ortholog-Specific Antibodies: For yeast studies, validate ABIN2786561 (86% homology) with knockout controls .